Clonidine Improves Spontaneous Baroreflex Sensitivity in Conscious Mice through Parasympathetic Activation

Hypertension

Volumn 43, Issue 5, 2004, Pages 1042-1047

  Tank, Jens ^a   Jordan, Jens ^a,c   Diedrich, André ^b   Obst, Michael ^c   Plehm, Ralph ^c   Luft, Friedrich C ^a,c   Gross, Volkmar ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b VANDERBILT UNIVERSITY   (United States)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Antihypertensive agents; Baroreflex; Blood pressure; Heart rate

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; ATROPINE; CLONIDINE; METOPROLOL; YOHIMBINE;

ALPHA ADRENERGIC RECEPTOR BLOCKING; ALPHA ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CHOLINERGIC STIMULATION; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; HEART RATE; HEART RATE VARIABILITY; MALE; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; TELEMETRY;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BAROREFLEX; BLOOD PRESSURE; CLONIDINE; CONSCIOUSNESS; HEART RATE; MALE; METOPROLOL; MICE; MONITORING, PHYSIOLOGIC; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, ADRENERGIC, ALPHA-2; RESPIRATION; SPECIES SPECIFICITY; SYMPATHETIC NERVOUS SYSTEM; TELEMETRY; YOHIMBINE;

EID: 2342594633     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000125884.49812.72     Document Type: Article

References (31)

1. Jordan J, Tank J, Shannon JR, Diedrich A, Lipp A, Schroeder C, Arnold G, Sharma AM, Biaggioni I, Robertson D, Luft FC. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation. 2002;105:1459-1464.
2. Sleight P, West MJ, Korner PI, Oliver JR, Chalmers JP, Robinson JL. The action of clonidine on the baroreflex control of heart rate in conscious animals and man, and on single aortic baroreceptor discharge in the rabbit. Arch Int Pharmacodyn Ther. 1975;214:4-11.
3. Head GA, Burke SL, Chan CK. Site and receptors involved in the sympathoinhibitory actions of rilmenidine. J Hypertens Suppl. 1998;16:S7-S12.
4. Gurtu S, Sinha JN, Bhargava KP. Involvement of alpha2-adrenoceptors of nucleus tractus solitarius in baroreflex mediated bradycardia. Naunyn Schmiedebergs Arch Pharmacol. 1982;321:38-43.
5. Makaritsis KP, Johns C, Gavras I, Altman JD, Handy DE, Bresnahan MR, Gavras H. Sympathoinhibitory function of the alpha(2A)-adrenergic receptor subtype. Hypertension. 1999;34:403-407.
6. Godwin SJ, Tortelli CF, Parkin ML, Head GA. Comparison of the baroreceptor-heart rate reflex effects of moxonidine, rilmenidine and clonidine in conscious rabbits. J Auton Nerv Syst. 1998;72:195-204.
7. Head GA. Baroreflexes and cardiovascular regulation in hypertension. J Cardiovasc Pharmacol. 1995;26:S7-S16.
8. Watkins L, Maixner W. Hypotensive effect of clonidine is not mediated by enhanced baroreflex gain in rats. J Cardiovasc Pharmacol. 1993;21:264-271.
9. Muzi M, Goff DR, Kampine JP, Roerig DL, Ebert TI. Clonidine reduces sympathetic activity but maintains baroreflex responses in normotensive humans. Anesthesiology. 1992;77:864-871.
10. Just A, Faulhaber J, Ehmke H. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol. 2000;279: R2214-R2221.
11. Gehrmann J, Hammer PE, Maguire CT, Wakimoto H, Triedman JK, Berul CI. Phenotypic screening for heart rate variability in the mouse. Am J Physiol Heart Circ Physiol. 2000;279:H733-H740.
12. Janssen BJ, Leenders PJ, Smits JF. Short-term and long-term blood pressure and heart rate variability in the mouse. Am J Physiol Regul Integr Comp Physiol. 2000;278:R215-R225.
13. Gross V, Plehm R, Tank J, Jordan J, Diedrich A, Obst M, Luft FC. Heart rate variability and baroreflex function in AT2 receptor-disrupted mice. Hypertension. 2002;40:207-213.
14. Hein L, Limbird LE, Eglen RM, Kobilka BK. Gene substitution/knockout to delineate the role of alpha 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines. Ann N Y Acad Sci. 1999;881:265-271.
15. Uhlen S, Porter AC, Neubig RR. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J Pharmacol Exp Ther. 1994;271:1558-1565.
16. Tan CM, Wilson MH, MacMillan LB, Kobilka BK, Limbird LE. Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists. Proc Natl Acad Sci U S A. 2002;99:12471-12476.
17. Bertinieri G, di Rienzo M, Cavallazzi A, Ferrari AU, Pedotti A, Mancia G. A new approach to analysis of the arterial baroreflex. J Hypertens Suppl. 1985;3:S79-S81.
18. Tank J, Jordan J, Diedrich A, Stoffels M, Franke G, Faulhaber HD, Luft FC, Busjahn A. Genetic influences on baroreflex function in normal twins. Hypertension. 2001;37:907-910.
19. deBoer RW, Karemaker JM, Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am J Physiol. 1987;253:H680-H689.
20. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, Sandrone G, Malfatto G, Dell'Orto S, Piccaluga E. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res. 1986;59:178-193.
21. Bucheler MM, Hadamek K, Hein L. Two alpha(2)-adrenergic receptor subtypes, alpha(2A) and alpha(2C), inhibit transmitter release in the brain of gene-targeted mice. Neuroscience. 2002;109:819-826.
22. Razzak A, Kawasaki H, Ueki S. Cardiovascular changes induced by large doses of clonidine in mice. Jpn J Pharmacol. 1977;27:437-444.
23. Duka I, Gavras I, Johns C, Handy DE, Gavras H. Role of the postsynaptic alpha(2)-adrenergic receptor subtypes in catecholamine-induced vasoconstriction. Gen Pharmacol. 2000;34:101-106.
24. Urban R, Szabo B, Starke K. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304. Eur J Pharmacol. 1995;282:29-37.
25. Janssen BJ, Smits JF. Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1545-R1564.
26. Gehrmann J, Meister M, Maguire CT, Martins DC, Hammer PE, Neer EJ, Berul CI, Mende U. Impaired parasympathetic heart rate control in mice with a reduction of functional G protein betagamma-subunits. Am J Physiol Heart Circ Physiol. 2002;282:H445-H456.
27. Robertson HA, Leslie RA. Noradrenergic alpha 2 binding sites in vagal dorsal motor nucleus and nucleus tractus solitarius: autoradiographic localization. Can J Physiol Pharmacol. 1985;63:1190-1194.
28. Tank J, Diedrich A, Szczech E, Luft FC, Jordan J. Alpha-2 Adrenergic Transmission and Human Baroreflex Regulation. Hypertension. 2004;(in press).
29. Makaritsis KP, Johns C, Gavras I, Gavras H. Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice. Hypertension. 2000;35:609-613.
30. Makaritsis KP, Handy DE, Johns C, Kobilka B, Gavras I, Gavras H. Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension. Hypertension. 1999;33:14-17.
31. Jones PP, Shapiro LF, Keisling GA, Jordan J, Shannon JR, Quaife RA, Seals DR. Altered autonomic support of arterial blood pressure with age in healthy men. Circulation. 2001;104:2424-2429.